| A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells M Moad, D Pal, AC Hepburn, SC Williamson, L Wilson, M Lako, ... European urology 64 (5), 753-761, 2013 | 98 | 2013 |
| In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells JK Blackwood, SC Williamson, LC Greaves, L Wilson, AC Rigas, ... The Journal of pathology 225 (2), 181-188, 2011 | 80 | 2011 |
| The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance AC Hepburn, RE Steele, R Veeratterapillay, L Wilson, EE Kounatidou, ... Oncogene 38 (22), 4412-4424, 2019 | 78 | 2019 |
| The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway AC Rigas, DM Ozanne, DE Neal, CN Robson Journal of biological chemistry 278 (46), 46087-46093, 2003 | 77 | 2003 |
| Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling AC Hepburn, R Veeratterapillay, SC Williamson, A El-Sherif, N Sahay, ... PloS one 7 (11), e50690, 2012 | 52 | 2012 |
| Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer AC Rigas, CN Robson, NJ Curtin Oncogene 26 (55), 7611-7619, 2007 | 38 | 2007 |
| Propagation of human prostate tissue from induced pluripotent stem cells AC Hepburn, EL Curry, M Moad, RE Steele, OE Franco, L Wilson, P Singh, ... stem cells translational medicine 9 (7), 734-745, 2020 | 28 | 2020 |
| Engineering prostate cancer from induced pluripotent stem cells—new opportunities to develop preclinical tools in prostate and prostate cancer studies AC Hepburn, CHC Sims, A Buskin, R Heer International journal of molecular sciences 21 (3), 905, 2020 | 20 | 2020 |
| Human α2β1HI CD133+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor SC Williamson, AC Hepburn, L Wilson, K Coffey, CA Ryan-Munden, D Pal, ... Plos one 7 (11), e48944, 2012 | 19 | 2012 |
| Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer SC Williamson, R Mitter, AC Hepburn, L Wilson, A Mantilla, HY Leung, ... British journal of cancer 109 (4), 950-956, 2013 | 17 | 2013 |
| Renal differentiation from adult spermatogonial stem cells R Heer, AC Hepburn, SC Williamson, A Kennedy, A El-Sherif, NA Soomro, ... Renal failure 35 (10), 1387-1391, 2013 | 14 | 2013 |
| Urothelial carcinoma stem cells: current concepts, controversies, and methods J Hatina, HS Parmar, M Kripnerova, A Hepburn, R Heer Urothelial Carcinoma: Methods and Protocols, 121-136, 2018 | 13 | 2018 |
| Identification of CNGB1 as a predictor of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer AC Hepburn, N Lazzarini, R Veeratterapillay, L Wilson, J Bacardit, R Heer Cancers 13 (15), 3903, 2021 | 9 | 2021 |
| ST6GAL1‐mediated aberrant sialylation promotes prostate cancer progression E Scott, E Archer Goode, R Garnham, K Hodgson, M Orozco‐Moreno, ... The Journal of pathology 261 (1), 71-84, 2023 | 5 | 2023 |
| Engineering prostate cancer in vitro: what does it take? A Buskin, E Scott, R Nelson, L Gaughan, CN Robson, R Heer, ... Oncogene 42 (32), 2417-2427, 2023 | 4 | 2023 |
| Phenotypic Modulation of Human Urinary Tract Stroma-derived Fibroblasts by Transforming Growth Factor β3 R Heer, N Clarke, AC Rigas, TR Cheek, R Pickard, HY Leung Urology 76 (2), 509. e13-509. e20, 2010 | 3 | 2010 |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer R Garnham, D Geh, R Nelson, E Ramon-Gil, L Wilson, EN Schmidt, ... Communications Biology 7 (1), 276, 2024 | 1 | 2024 |
| Reply from Authors re: Felix Wezel, Jennifer Southgate. Reprogramming Stromal Cells from the Urinary Tract and Prostate: A Trip to Pluripotency and Back? Eur Urol 2013; 64: 762–4 D Pal, M Moad, AC Hepburn, SC Williamson, CN Robson, R Heer European Urology 5 (64), 764-765, 2013 | 1 | 2013 |
| ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer R Garnham, D Geh, R Nelson, E Ramon-Gill, L Wilson, EN Schmidt, ... bioRxiv, 2023.04. 03.535346, 2023 | | 2023 |
| Human Prostate Stem Cells and Their Niche-A Comprehensive Review S Subramanian, R Geraghty, AC Hepburn, L Wilson, R Heer J Stem Cell Res Dev Ther 5, 020, 2019 | | 2019 |
